D. Ospedale-san-martino, I. Haematology, . Genova, . Italy-;-ospedale-san-raffaele-s.-r, B. Haematology et al., European Institute of Oncology Reggio Calabria , Italy; Baskent University Hospital, Haematology Division Adana, Turkey; CHU Nantes, Department D'Hematologie King Faisal Specialist Hospital & Research Centre, Oncology (Section of Adult Haematolgy/BMT), Riyadh, Saudi Arabia; University of Cologne, I. Department of Medicine, Cologne, Germany; Ospedale San Gerardo, Clinica Ematologica dell'Universita Milano-Biocca Klinkum Rechts der Isar, III Med Klinik der TU, Munich, Germany; University of Napoli, 'Federico II' Medical School, Division of Hematology Hopital Saint Antoine, Department of Hematology Adult and Paediatric Transplant Centre Belgium; Specialized Children's Oncohematology Hospital, Citta della Salute e della Scienza di Torino Klinik und Poliklinik II

R. Siegel, K. Miller, and A. Jemal, Cancer statistics, 2016, CA: A Cancer Journal for Clinicians, vol.61, issue.suppl 3, pp.7-30, 2016.
DOI : 10.1111/obr.12321

H. Inaba, M. Greaves, and C. Mullighan, Acute lymphoblastic leukaemia, The Lancet, vol.381, issue.9881, pp.1943-55, 2013.
DOI : 10.1016/S0140-6736(12)62187-4

E. Jabbour, O. Brien, S. Konopleva, M. Kantarjian, and H. , New insights into the pathophysiology and therapy of adult acute lymphoblastic leukemia, Cancer, vol.124, issue.1, pp.2517-2545, 2015.
DOI : 10.1002/cncr.29383

J. Sive, G. Buck, A. Fielding, H. Lazarus, M. Litzow et al., Outcomes in older adults with acute lymphoblastic leukaemia (ALL): results from the international MRC UKALL XII/ECOG2993 trial, British Journal of Haematology, vol.93, issue.4, pp.463-71, 2012.
DOI : 10.1111/j.1365-2141.2012.09095.x

H. Kantarjian, D. Thomas, S. O-'brien, J. Cortes, F. Giles et al., Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia, Cancer, vol.97, issue.12, pp.2788-801, 2004.
DOI : 10.1002/cncr.20668

N. Gokbuget, D. Stanze, J. Beck, H. Diedrich, H. Horst et al., Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation, Blood, vol.120, issue.10, pp.2032-2073, 2012.
DOI : 10.1182/blood-2011-12-399287

A. Goldstone, S. Richards, H. Lazarus, M. Tallman, G. Buck et al., In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993), Blood, vol.111, issue.4, pp.1827-1860, 2008.
DOI : 10.1182/blood-2007-10-116582

X. Thomas, J. Boiron, F. Huguet, H. Dombret, K. Bradstock et al., Outcome of Treatment in Adults With Acute Lymphoblastic Leukemia: Analysis of the LALA-94 Trial, Journal of Clinical Oncology, vol.22, issue.20, pp.4075-86, 2004.
DOI : 10.1200/JCO.2004.10.050

A. Sureda, P. Bader, S. Cesaro, P. Dreger, R. Duarte et al., Indications for allo- and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015, Bone Marrow Transplantation, vol.2012, issue.8, pp.1037-56, 2015.
DOI : 10.1038/bmt.2015.6

V. Gupta, S. Richards, and R. J. , Allogeneic, but not autologous, hematopoietic cell transplantation improves survival only among younger adults with acute lymphoblastic leukemia in first remission: an individual patient data meta-analysis, Blood, vol.121, issue.2, pp.339-50, 2013.
DOI : 10.1182/blood-2012-07-445098

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186648

D. Oliansky, R. Larson, D. Weisdorf, H. Dillon, T. Ratko et al., The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Adult Acute Lymphoblastic Leukemia: Update of the 2006 Evidence-Based Review, Biology of Blood and Marrow Transplantation, vol.18, issue.1, pp.18-36, 2012.
DOI : 10.1016/j.bbmt.2011.07.019

A. Messori, V. Fadda, D. Maratea, and S. Trippoli, Acute lymphoblastic leukemia in first complete remission: temporal trend of outcomes in studies comparing allogeneic transplant with autologous transplant or chemotherapy, Annals of Hematology, vol.123, issue.6, pp.1221-1229, 2013.
DOI : 10.1007/s00277-013-1766-5

S. Ciurea and U. Bayraktar, ?No donor?? Consider a haploidentical transplant, Blood Reviews, vol.29, issue.2, pp.63-70, 2015.
DOI : 10.1016/j.blre.2014.09.009

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4379127

L. Tucunduva, A. Ruggeri, G. Sanz, S. Furst, G. Socié et al., Risk factors for outcomes after unrelated cord blood transplantation for adults with acute lymphoblastic leukemia: a report on behalf of Eurocord and the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation, Bone Marrow Transplantation, vol.90, issue.7, pp.887-94, 2014.
DOI : 10.1182/blood-2012-06-379040

J. Passweg, H. Baldomero, P. Bader, C. Bonini, S. Cesaro et al., Hematopoietic SCT in Europe 2013: recent trends in the use of alternative donors showing more haploidentical donors but fewer cord blood transplants, Bone Marrow Transplantation, vol.8, issue.4, pp.476-82, 2015.
DOI : 10.1016/j.bbmt.2014.05.015

C. Kanakry, E. Fuchs, and L. Luznik, Modern approaches to HLA-haploidentical blood or marrow transplantation, Nature Reviews Clinical Oncology, vol.5, issue.1, pp.10-24, 2016.
DOI : 10.1182/blood-2007-03-082933

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695979

L. Luznik, O. Donnel, P. Fuchs, and E. , Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation, Seminars in Oncology, vol.39, issue.6, pp.683-93, 2012.
DOI : 10.1053/j.seminoncol.2012.09.005

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808078

A. Raiola, A. Dominietto, A. Ghiso, D. Grazia, C. Lamparelli et al., Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning, Biology of Blood and Marrow Transplantation, vol.19, issue.1, pp.117-139, 2013.
DOI : 10.1016/j.bbmt.2012.08.014

URL : http://doi.org/10.1016/j.bbmt.2012.08.014

D. Bartolomeo, P. Santarone, S. De, A. Picardi, A. Cudillo et al., Haploidentical, unmanipulated, G-CSF-primed bone marrow transplantation for patients with high-risk hematologic malignancies, Blood, vol.121, issue.5, pp.849-57, 2013.
DOI : 10.1182/blood-2012-08-453399

Y. Wang, Q. Liu, L. Xu, K. Liu, X. Zhang et al., Haploidentical versus Matched-Sibling Transplant in Adults with Philadelphia-Negative High-Risk Acute Lymphoblastic Leukemia: A Biologically Phase III Randomized Study, Clinical Cancer Research, vol.22, issue.14, pp.3467-76, 2016.
DOI : 10.1158/1078-0432.CCR-15-2335

Y. Chang and X. Huang, Haploidentical stem cell transplantation: anti-thymocyte globulin-based experience, Seminars in Hematology, vol.53, issue.2, pp.82-91, 2016.
DOI : 10.1053/j.seminhematol.2016.01.004

B. Savani, M. Labopin, N. Kröger, J. Finke, G. Ehninger et al., Expanding transplant options to patients over 50 years. Improved outcome after reduced intensity conditioning mismatched-unrelated donor transplantation for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the EBMT, Haematologica, vol.101, issue.6, pp.773-80, 2016.
DOI : 10.3324/haematol.2015.138180

S. Piemontese, F. Ciceri, M. Labopin, A. Bacigalupo, H. Huang et al., A survey on unmanipulated haploidentical hematopoietic stem cell transplantation in adults with acute leukemia, Leukemia, vol.15, issue.5, pp.1069-75, 2015.
DOI : 10.1182/blood-2011-03-344853

S. Piemontese, F. Ciceri, M. Labopin, W. Arcese, S. Kyrcz-krzemien et al., A comparison between allogeneic stem cell transplantation from unmanipulated haploidentical and unrelated donors in acute leukemia, Journal of Hematology & Oncology, vol.33, issue.9, p.24, 2017.
DOI : 10.1186/s13045-017-0394-2

URL : https://hal.archives-ouvertes.fr/hal-01501594

A. Ruggeri, M. Labopin, G. Sanz, S. Piemontese, W. Arcese et al., Comparison of outcomes after unrelated cord blood and unmanipulated haploidentical stem cell transplantation in adults with acute leukemia, Leukemia, vol.90, issue.9, pp.1891-900, 2015.
DOI : 10.1182/blood-2008-02-140095

S. Srour, D. Milton, A. Bashey, A. Karduss-urueta, A. Malki et al., Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for High-Risk Acute Lymphoblastic Leukemia, Biology of Blood and Marrow Transplantation, vol.23, issue.2, pp.318-342, 2017.
DOI : 10.1016/j.bbmt.2016.11.008

A. Bacigalupo, K. Ballen, D. Rizzo, S. Giralt, H. Lazarus et al., Defining the Intensity of Conditioning Regimens: Working Definitions, Biology of Blood and Marrow Transplantation, vol.15, issue.12, pp.1628-1661, 2009.
DOI : 10.1016/j.bbmt.2009.07.004

A. Ruggeri, M. Labopin, F. Ciceri, M. Mohty, and A. Nagler, Definition of GvHD-free, relapse-free survival for registry-based studies: an ALWP?EBMT analysis on patients with AML in remission, Bone Marrow Transplantation, vol.18, issue.4, pp.610-611, 2016.
DOI : 10.3324/haematol.2013.092254

S. Lee, G. Vogelsang, and M. Flowers, Chronic graft-versus-host disease, Biology of Blood and Marrow Transplantation, vol.9, issue.4, pp.215-248, 2003.
DOI : 10.1053/bbmt.2003.50026

URL : https://hal.archives-ouvertes.fr/hal-00849664

P. Hoogard, Frailty models for survival data, Lifetime Data Analysis, vol.35, issue.3, pp.255-73, 1995.
DOI : 10.1007/BF00985760

P. Andersen, J. Klein, and M. Zhang, Testing for centre effects in multi-centre survival studies: a Monte Carlo comparison of fixed and random effects tests, Statistics in Medicine, vol.84, issue.12, pp.1489-500, 1999.
DOI : 10.1002/(SICI)1097-0258(19990630)18:12<1489::AID-SIM140>3.0.CO;2-#

S. Giebel, M. Labopin, G. Socié, D. Beelen, D. Beelen et al., Improving results of allogeneic hematopoietic cell transplantation for adults with acute lymphoblastic leukemia in first complete remission: an analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation, Haematologica, vol.102, issue.1, pp.139-188, 2017.
DOI : 10.3324/haematol.2016.145631

URL : https://hal.archives-ouvertes.fr/hal-01470403

J. Pavl?, M. Labopin, A. Zoellner, I. Sakellari, M. Stelljes et al., Allogeneic hematopoietic cell transplantation for primary refractory acute lymphoblastic leukemia: A report from the Acute Leukemia Working Party of the EBMT, Cancer, vol.8, issue.11, 2017.
DOI : 10.2217/imt-2015-0023

M. Topp, N. Gökbuget, A. Stein, G. Zugmaier, O. Brien et al., Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study, The Lancet Oncology, vol.16, issue.1, pp.57-66, 2015.
DOI : 10.1016/S1470-2045(14)71170-2

H. Kantarjian, D. Deangelo, M. Stelljes, G. Martinelli, M. Liedtke et al., Inotuzumab Ozogamicin versus Standard Therapy for Acute Lymphoblastic Leukemia, New England Journal of Medicine, vol.375, issue.8, pp.740-53, 2016.
DOI : 10.1056/NEJMoa1509277

S. Maude, N. Frey, P. Shaw, R. Aplenc, D. Barrett et al., Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia, New England Journal of Medicine, vol.371, issue.16, pp.1507-1524, 2014.
DOI : 10.1056/NEJMoa1407222

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4267531

D. Lee, J. Kochenderfer, M. Stetler-stevenson, Y. Cui, C. Delbrook et al., T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial, The Lancet, vol.385, issue.9967, pp.517-545, 2015.
DOI : 10.1016/S0140-6736(14)61403-3

M. Rubio, B. Savani, M. Labopin, S. Piemontese, E. Polge et al., Impact of conditioning intensity in T-replete haplo-identical stem cell transplantation for acute leukemia: a report from the acute leukemia working party of the EBMT, Journal of Hematology & Oncology, vol.69, issue.2, p.25, 2016.
DOI : 10.1186/s13045-016-0248-3

URL : https://hal.archives-ouvertes.fr/hal-01297485

O. Donnell, P. Eapen, M. Horowitz, M. Logan, B. Digilio et al., Comparable outcomes with marrow or peripheral blood as stem cell sources for hematopoietic cell transplantation from haploidentical donors after non-ablative conditioning: a matched-pair analysis, Bone Marrow Transplantation, vol.23, issue.12, pp.1599-601, 2016.
DOI : 10.1126/scitranslmed.3006960

L. Castagna, R. Crocchiolo, S. Furst, S. Bramanti, E. Cheikh et al., Bone Marrow Compared with Peripheral Blood Stem Cells for Haploidentical Transplantation with a Nonmyeloablative Conditioning Regimen and Post-transplantation Cyclophosphamide, Biology of Blood and Marrow Transplantation, vol.20, issue.5, pp.724-733, 2014.
DOI : 10.1016/j.bbmt.2014.02.001

URL : http://doi.org/10.1016/j.bbmt.2014.02.001

S. Giebel, A. Czyz, O. Ottmann, F. Baron, E. Brissot et al., Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the, Cancer, vol.50, issue.suppl 2, pp.2941-51, 2016.
DOI : 10.1002/cncr.30130

N. Dhédin, A. Huynh, S. Maury, R. Tabrizi, K. Beldjord et al., Role of allogeneic stem cell transplantation in adult patients with Ph-negative acute lymphoblastic leukemia, Blood, vol.125, issue.16, pp.2486-96, 2015.
DOI : 10.1182/blood-2014-09-599894